
A two-year study involving 211 actively treated gout patients reveals that anthropometric measures remained stable while lipid levels decreased. Higher waist circumference (WC) at baseline reduced the likelihood of achieving the serum urate (sUA) target at year 2, whereas high levels of high-density lipoprotein cholesterol increased the chance. Elevated low-density lipoprotein cholesterol predicted gout flares during the second year. The findings suggest that, in gout management, attention to WC and lipid levels is crucial for predicting unfavorable outcomes despite stable anthropometric measures and reduced lipid levels over time.
Like
Save
Share